There are very few people who are really opposed to improving health. The difficult parts are the questions of what to spend money on researching and the interplay with regulation.
2 Likes
I was referring to his potential influence over regulatory requirements for approval of new drugs and other interventions.
I don’t like the combination of cutting science research across the board (including longevity) , and loosening regulations for new drugs. Time may tell how this will turn out, and it’s hopefully for the best.
True, we don’t know how it will play out. If he’s a longevity enthusiast, as the article says, he would be closer to a typical member of this forum than to a traditional health bureaucrat.
1 Like
Jim O’neil is definitely a longevity enthusiast; he attends many of the longevity meetings around the country and I’ve met him at one. He is Peter Thiel’s “go to guy” for all things longevity. We’ll see what sort of influence he has in the new administration…
4 Likes
It’s the best thing that this administration has ever done. Jim O’Neill has always been at the right side of everything far ahead of time - be it the Thiel Fellowship, psychedelic advocacy, and “right to try” laws.
He’s even tpot-adjacent, and maybe the most open-minded person in a long time in government.
I know that many Thiel Fellows (eg Chris Olah) also have very high opinion of him.
3 Likes
It’s complicated but we should start with optimism.
AnUser
#9
A hope? A chance.
[Bryan Johnson] met with Republican representatives from Pennsylvania, Tennessee and Texas as well as HHS Deputy Secretary Jim O’Neil and Michael Kratsios, the White House director of the Office of Science and Technology.
https://www.politico.com/newsletters/future-pulse/2025/06/27/bryan-johnson-wants-congress-to-sleep-00428129
2 Likes
